Misplaced Pages

Broxyquinoline: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 17:29, 7 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validati← Previous edit Latest revision as of 01:36, 9 April 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers174,373 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
(22 intermediate revisions by 16 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443536496
| IUPAC_name = 5,7-Dibromoquinolin-8-ol
| image = Broxyquinoline.png
| alt = Skeletal formula of broxyquinoline
| width = 145
| image2 = Broxyquinoline 3D ball.png
| alt2 = Ball-and-stick model of the broxyquinoline molecule
| width2 = 160

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|broxyquinoline}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 521-74-4
| ATC_prefix = A07
| ATC_suffix = AX01
| ATC_supplemental = {{ATC|G01|AC06}} {{ATC|P01|AA01}}
| PubChem = 2453
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 223448
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UK4C618C8T | UNII = UK4C618C8T
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| verifiedrevid = 437201596
| ChemSpiderID = 2359
| IUPAC_name = 5,7-Dibromoquinolin-8-ol
| smiles = Brc1c(O)c2ncccc2c(Br)c1
| image = Broxyquinoline.png
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| CAS_number = 521-74-4
| StdInChI = 1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
| ATC_prefix = A07
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| ATC_suffix = AX01
| StdInChIKey = ZDASUJMDVPTNTF-UHFFFAOYSA-N
| ATC_supplemental = {{ATC|P01|AA01}}

| PubChem = 2453
<!--Chemical data-->
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = | C=9 | H=5 | Br=2 | N=1 | O=1
| C=9|H=5|Br=2|N=1|O=1
| molecular_weight = 302.95 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}} }}


'''Broxyquinoline''' is an ] agent.{{cn|date=February 2023}}An association with ] has been reported.<ref name="pmid3081430">{{cite journal | vauthors = Swain R, Bapna JS | title = Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination | journal = Human Toxicology | volume = 5 | issue = 1 | pages = 63–4 | date = January 1986 | pmid = 3081430 | doi = 10.1177/096032718600500115 | s2cid = 23922563 }}</ref>
'''Broxyquinoline''' is an anti-infective.


== References ==
An association with ] has been reported.<ref name="pmid3081430">{{cite journal |author=Swain R, Bapna JS |title=Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination |journal=Hum Toxicol |volume=5 |issue=1 |pages=63–4 |year=1986 |month=January |pmid=3081430 |doi= 10.1177/096032718600500115|url=}}</ref>

==References==
{{reflist}} {{reflist}}



{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}} {{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}
{{Agents against amoebozoa}} {{Agents against amoebozoa}}


] ]
] ]
] ]



{{gastrointestinal-drug-stub}} {{gastrointestinal-drug-stub}}
Broxyquinoline: Difference between revisions Add topic